Scientists Map 19,000+ Genes to Unlock CRISPR’s Full Potential

Scientists Map 19,000+ Genes to Unlock CRISPR’s Full Potential

UW–Madison researchers identify genes that block CRISPR success, offering a roadmap for safer gene therapy—particularly for inherited eye diseases.

LS
Linsey Smith
Aug 13, 2026
1 min read

Researchers at the University of Wisconsin–Madison have developed a high-throughput platform to screen nearly all of the more than 19,000 human genes, identifying those that hinder the success of CRISPR-Cas9 gene editing. Published in Nature Communications on August 13, 2026, the work provides a critical roadmap for improving nonviral genetic editing technologies—particularly for treating genetic eye diseases where delivery and editing efficiency remain major barriers.

This breakthrough builds on a wave of CRISPR innovation. Scientists at the University of Florida recently developed the world's first DNA-guided CRISPR system, which uses stable DNA guides instead of RNA to target genetic material with greater precision and lower cost. Meanwhile, researchers from Purdue and Columbia universities discovered a natural CRISPR variant that turns genes on without cutting DNA which basically is a gentler alternative that could lead to safer medical treatments.

AI is also accelerating the field: Stanford Medicine's CRISPR-GPT helps researchers plan experiments faster, cutting drug development timelines from years to months. The UW–Madison platform now adds another layer by revealing which genes act as roadblocks, enabling researchers to bypass them and unlock CRISPR's full therapeutic potential.

About the Writer

More from Mindplex

Keep reading

Three more ideas worth your time.

Browse MindBytes

Discussion

Join the discussion

Sign in to share a response with the community.

Type @ to mention someone Type / or use + to add a block Highlight text, then choose Link
Loading editor

Comments cannot be edited after posting because they become part of the reputation record. Give yours a quick review first.